Science Magazine | AAAS: Science Translational Medicine Follow Neurotensin receptor 2 agonism attenuates adverse cardiac remodeling in preclinical models | Science Translational Medicine Neurotensin is an endogenous inhibitor of adverse cardiac remodeling. https://www.science.org/doi/10.1126/scitranslmed.aea9877 science.org
